Soluble fiber supplement for fatty liver in kids
Part of Digestive system clinical trials.
This Phase 2 study tests whether a soluble fiber supplement can improve fatty liver disease in children who have obesity and confirmed NAFLD. It may help reduce liver fat and related liver enzyme elevations measured during clinic visits and MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 8 to 17 years old
- Have obesity based on BMI for age (at least 2 standard deviations above the WHO median)
- Be enrolled in the GHWM Clinic
- Have NAFLD confirmed at the clinic (higher ALT blood test and fatty liver seen on clinic assessment, including liver fat)
- Be able to do MRI for the study (not claustrophobic, no metal implants, and under 300 lbs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fructose (a type of sugar) may affect fatty liver disease (NAFLD) in teens with obesity. The goal is to learn whether fructose changes liver health, using MRI/MRS scans to measure the liver.
This trial looks at nonalcoholic steatohepatitis (fatty liver with inflammation) in children. It is meant to test whether a new approach can help improve this liver problem without being caused by alcohol or other known liver diseases.
This study tests whether intermittent fasting can improve fatty liver disease (NAFLD) by reducing liver fat. It focuses on adults with confirmed fatty liver and extra liver fat seen on a special MRI scan.
This trial tests if drinking soymilk can improve liver health in children who are overweight or have a fatty liver. It compares soymilk to cow's milk to see which is better for reducing liver fat.
This study tests whether a medicine called empagliflozin (a type of SGLT2 inhibitor) can help treat non-alcoholic fatty liver disease in adolescents with obesity. It aims to see if the drug can reduce fat in the liver and improve liver health.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
Hear when a new Hepatic Steatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.